» Articles » PMID: 33529569

SARS-CoV-2 Seropositivity Among US Marine Recruits Attending Basic Training, United States, Spring-Fall 2020

Overview
Date 2021 Feb 2
PMID 33529569
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

In a study of US Marine recruits, seroprevalence of severe acute respiratory syndrome coronavirus 2 IgG was 9.0%. Hispanic and non-Hispanic Black participants and participants from states affected earlier in the pandemic had higher seropositivity rates. These results suggest the need for targeted public health strategies among young adults at increased risk for infection.

Citing Articles

Anti-SARS-CoV-2 Antibody Testing: Role and Indications.

Mink S, Fraunberger P J Clin Med. 2023; 12(24).

PMID: 38137643 PMC: 10744049. DOI: 10.3390/jcm12247575.


High baseline frequencies of natural killer cells are associated with asymptomatic SARS-CoV-2 infection.

Graydon E, Malloy A, Machmach K, Sun P, Paquin-Proulx D, Lizewski S Curr Res Immunol. 2023; 4:100064.

PMID: 37645658 PMC: 10461189. DOI: 10.1016/j.crimmu.2023.100064.


Assessment of immunoglobin G (spike and nucleocapsid protein) response to COVID-19 vaccination in Palestine.

Asmar I, Almahmoud O, Yaseen K, Jamal J, Omar A, Naseef H Clin Epidemiol Glob Health. 2023; 22:101330.

PMID: 37293133 PMC: 10239151. DOI: 10.1016/j.cegh.2023.101330.


COVID-19 Vaccination Attitudes and Intentions Among U.S. Soldiers: Results from the U.S. Army Behavioral Health Advisory Team (BHAT).

Beymer M, Gomez S, Santo T, Bell A, Quartana P J Community Health. 2022; 48(2):228-237.

PMID: 36370254 PMC: 9652595. DOI: 10.1007/s10900-022-01149-6.


Genomic and virologic characterization of samples from a shipboard outbreak of COVID-19 reveals distinct variants within limited temporospatial parameters.

Cer R, Voegtly L, Adhikari B, Pike B, Lueder M, Glang L Front Microbiol. 2022; 13:960932.

PMID: 36033872 PMC: 9399806. DOI: 10.3389/fmicb.2022.960932.


References
1.
Cunningham J, Vaduganathan M, Claggett B, Jering K, Bhatt A, Rosenthal N . Clinical Outcomes in Young US Adults Hospitalized With COVID-19. JAMA Intern Med. 2020; . PMC: 7489373. DOI: 10.1001/jamainternmed.2020.5313. View

2.
Nivette A, Ribeaud D, Murray A, Steinhoff A, Bechtiger L, Hepp U . Non-compliance with COVID-19-related public health measures among young adults in Switzerland: Insights from a longitudinal cohort study. Soc Sci Med. 2020; 268:113370. PMC: 7493799. DOI: 10.1016/j.socscimed.2020.113370. View

3.
Bajema K, Wiegand R, Cuffe K, Patel S, Iachan R, Lim T . Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020. JAMA Intern Med. 2020; 181(4):450-460. PMC: 7686880. DOI: 10.1001/jamainternmed.2020.7976. View

4.
Anand S, Montez-Rath M, Han J, Bozeman J, Kerschmann R, Beyer P . Prevalence of SARS-CoV-2 antibodies in a large nationwide sample of patients on dialysis in the USA: a cross-sectional study. Lancet. 2020; 396(10259):1335-1344. PMC: 7518804. DOI: 10.1016/S0140-6736(20)32009-2. View

5.
Dong E, Du H, Gardner L . An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis. 2020; 20(5):533-534. PMC: 7159018. DOI: 10.1016/S1473-3099(20)30120-1. View